Showing results (261-270 of 948) with videos related to

Sort By:
Pageof 95
Respirology (Carlton, Vic.)|October 24, 2015
Polymicrobial community-acquired pneumonia: An emerging entityCatia Cillóniz, Rok Civljak, Antonello Nicolini, et al.
Microorganisms|February 15, 2019
PES Pathogens in Severe Community-Acquired PneumoniaCatia Cillóniz, Cristina Dominedò, Antonello Nicolini, et al.
Expert Opinion on Pharmacotherapy|May 17, 2019
Perspectives on synthetic pharmacotherapy for the treatment of nosocomial pneumoniaAna Motos, Hua Yang, Minlan Yang, et al.
Seminars in Respiratory and Critical Care Medicine|June 22, 2012
Biomarkers and community-acquired pneumonia: tailoring management with biological dataAntoni Torres, Paula Ramirez, Beatriz Montull, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|December 5, 2023
Corticosteroids in sepsis and community-acquired pneumoniaAmedeo Guzzardella, Ana Motos, Jordi Vallverdú, et al.
Intensive Care Medicine|March 19, 2014
Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort studyJordi Vallés, Ignacio Martin-Loeches, Antoni Torres, et al.
The European Respiratory Journal|April 3, 2023
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumoniaIgnacio Martin-Loeches, Antoni Torres, Blin Nagavci, et al.
Critical Care Medicine|October 3, 2015
Being Overweight Is Associated With Greater Survival in ICU Patients: Results From the Intensive Care Over Nations AuditYasser Sakr, Ilmi Alhussami, Rahul Nanchal, et al.
Intensive Care Medicine Experimental|July 2, 2021
The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsisMark E Nunnally, Ricard Ferrer, Greg S Martin, et al.
Jac-Antimicrobial Resistance|June 30, 2021
Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infectionLiam Townsend, Gerry Hughes, Colm Kerr, et al.
Pageof 95